Literature DB >> 1782308

The effect of bile acids on the growth and adherence of Helicobacter pylori.

E Mathai1, A Arora, M Cafferkey, C T Keane, C O'Morain.   

Abstract

Bile reflux gastritis occurs in the absence of Helicobacter pylori (H. pylori). The aim of this study was to see if the bile acids cheno or ursodeoxycholic acid affected the growth or adherence of H. pylori in vitro. Twenty-seven strains growth were inhibited by 0.1% chenodeoxycholic acid whereas only 11 out of the 27 were inhibited by 0.1% ursodeoxycholic acid. Growth was totally inhibited by a combination of 0.05% chenodeoxycholic acid +0.05% ursodeoxycholic acid. Chenodeoxycholic acid was a more effective inhibitor of adherence in that the number inhibited and percentage inhibition were greater than with ursodeoxycholic acid. Bile salts might be useful in the treatment of H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1782308     DOI: 10.1111/j.1365-2036.1991.tb00533.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  11 in total

1.  Cell proliferation in the post-surgical stomach, dietary salt, and the effect of H pylori eradication.

Authors:  P Willis; D A Lynch; R Prescott; S Lamonby
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile salts.

Authors:  Elizabeth A Trainor; Katherine E Horton; Paul B Savage; Traci L Testerman; David J McGee
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Gastric cancer precursor lesions and Helicobacter pylori infection in patients with partial gastrectomy for peptic ulcer.

Authors:  Andrea Giuliani; Alessandro Caporale; Martino Demoro; Eugenio Benvenuto; Massimo Scarpini; Sebastiano Spada; Francesco Angelico
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

4.  Duodenal switch operation for pathologic transpyloric duodenogastric reflux.

Authors:  Paolo Strignano; Jean-Marie Collard; Jean-Marie Michel; Renato Romagnoli; Jean-Paul Buts; Charles De Gheldere; Francesco Volonté; Mauro Salizzoni
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

5.  DNA methylation genome-wide analysis in remnant and primary gastric cancers.

Authors:  Kiichi Sugimoto; Tomoaki Ito; Alicia Hulbert; Chen Chen; Hajime Orita; Masahiro Maeda; Hiroshi Moro; Takeo Fukagawa; Toshikazu Ushijima; Hitoshi Katai; Ryo Wada; Koichi Sato; Kazuhiro Sakamoto; Wayne Yu; Michael Considine; Leslie Cope; Malcolm V Brock
Journal:  Gastric Cancer       Date:  2019-03-12       Impact factor: 7.370

Review 6.  Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?

Authors:  Birgit Terjung; Ulrich Spengler
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

7.  T-cell function is critical for murine cholesterol gallstone formation.

Authors:  Kirk J Maurer; Varada P Rao; Zhongming Ge; Arlin B Rogers; Trisha J Oura; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2007-10       Impact factor: 22.682

Review 8.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

9.  Helicobacter pylori may induce bile reflux: link between H pylori and bile induced injury to gastric epithelium.

Authors:  S D Ladas; J Katsogridakis; H Malamou; H Giannopoulou; M Kesse-Elia; S A Raptis
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

10.  Morpho-functional gastric pre-and post-operative changes in elderly patients undergoing laparoscopic cholecystectomy for gallstone related disease.

Authors:  Giovanni Aprea; Alfonso Canfora; Antonio Ferronetti; Antonio Giugliano; Francesco Guida; Antonio Braun; Melania Battaglini Ciciriello; Federica Tovecci; Giovanni Mastrobuoni; Fabrizio Cardin; Bruno Amato
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.